We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $3.01B
1-Year Est. Return 119.46%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+119.46%
3 Year Est. Return
+340.9%
5 Year Est. Return
+347.01%
10 Year Est. Return
+3,143.27%
AUM
$3.27B
AUM Growth
-$46.7M
Cap. Flow
-$11.4M
Cap. Flow %
-0.35%
Top 10 Hldgs %
56.15%
Holding
134
New
19
Increased
35
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$44.1M
2
FCFS icon
FirstCash
FCFS
+$26.4M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
+$20.4M
4
FTIVU
FinTech Acquisition Corp. IV Unit
FTIVU
+$20M
5
AKU
Akumin Inc
AKU
+$17.2M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$39.3M
2
MED icon
Medifast
MED
+$37.9M
3
THC icon
Tenet Healthcare
THC
+$37.4M
4
HCA icon
HCA Healthcare
HCA
+$30.4M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$22.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.49%
2 Healthcare 19.64%
3 Consumer Discretionary 6.13%
4 Industrials 4.77%
5 Technology 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$77.1B
$674M 20.62%
4,500,000
+400,000
+10% +$60.2M
W icon
2
CALL
Wayfair
W
$14B
$379M 11.61%
1,304,000
– –
CVNA icon
3
CALL
Carvana
CVNA
$47.5B
$231M 7.06%
5,174,000
-3,838,000
-43% -$136M
LNW
4
CALL
DELISTED
Light & Wonder
LNW
$151M 4.62%
4,328,600
– –
IWM icon
5
CALL
iShares Russell 2000 ETF
IWM
$77.1B
$105M 3.21%
700,000
-500,000
-42% -$75.2M
CDXS icon
6
Codexis
CDXS
$141M
$63M 1.93%
5,363,484
– –
DLB icon
7
Dolby
DLB
$5.43B
$62.2M 1.9%
938,656
+8,463
+0.9% +$573K
THC icon
8
CALL
Tenet Healthcare
THC
$21.1B
$58.9M 1.8%
2,402,500
– –
QURE icon
9
uniQure
QURE
$3.06B
$58.3M 1.78%
1,583,358
+15,209
+1% +$623K
VG
10
DELISTED
Vonage Holdings Corporation
VG
$53M 1.62%
5,183,712
+50,412
+1% +$559K
QADA
11
DELISTED
QAD Inc.
QADA
$50M 1.53%
1,184,365
+10,497
+0.9% +$441K
VAC icon
12
Marriott Vacations Worldwide
VAC
$3.6B
$47.9M 1.47%
527,683
-13,950
-3% -$1.27M
APTO
13
DELISTED
Aptose Biosciences, Inc.
APTO
$41.3M 1.26%
15,309
+2,027
+15% +$5.05M
TNL icon
14
Travel + Leisure Co
TNL
$3.93B
$40.1M 1.23%
1,304,435
+310,496
+31% +$9.27M
CAR icon
15
PUT
Avis
CAR
$4.05B
$39.5M 1.21%
1,500,000
– –
QURE icon
16
CALL
uniQure
QURE
$3.06B
$39.1M 1.2%
1,062,500
– –
TFFP
17
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$37.5M 1.15%
81,320
+47,059
+137% +$13.3M
ESTA icon
18
Establishment Labs
ESTA
$2.07B
$35.6M 1.09%
1,919,190
+11,477
+0.6% +$204K
CUE icon
19
Cue Biopharma
CUE
$269M
$35.3M 1.08%
78,074
+561
+0.7% +$323K
BMY.RT
20
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$34.7M 1.06%
+15,437,336
New +$44.1M
CASH icon
21
Pathward Financial
CASH
$1.61B
$34.6M 1.06%
1,799,727
– –
IMXI icon
22
International Money Express
IMXI
$378M
$33.3M 1.02%
2,318,668
-594,022
-20% -$9.06M
FBIO icon
23
Fortress Biotech
FBIO
$83.4M
$33.2M 1.02%
548,329
+253,333
+86% +$12.9M
GDEN
24
DELISTED
Golden Entertainment
GDEN
$29.4M 0.9%
2,127,788
– –
LXFR icon
25
Luxfer Holdings
LXFR
$461M
$28.6M 0.87%
2,277,665
+24,193
+1% +$329K
1
2 3 4 5

Similar funds

MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $3.02B AUM 91.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
HP
Hosking Partners London, United Kingdom $3.01B AUM 83.99% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Nantahala Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Nantahala Capital Management held 134 positions worth $3.27B, down 1.4% from $3.32B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management's Q3 2020 filing shows 19 new, 35 increased, 23 reduced and 20 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 15,437,336 shares worth $34.7M. The largest sale was RH, an estimated $39.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 55% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nantahala Capital Management's largest Q3 2020 buy was Bristol-Myers Squibb Company Contingent Value Rights: 15,437,336 shares worth $34.7M.
  • Nantahala Capital Management added most to TravelCenters of America LLC in Q3 2020, an estimated $16.5M increase.
  • Nantahala Capital Management's biggest Q3 2020 reduction was Tenet Healthcare, cutting an estimated $37.4M.
  • Nantahala Capital Management fully exited RH in Q3 2020, selling an estimated $39.3M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $3.27B portfolio in Q3 2020.
  • Nantahala Capital Management opened 19 new positions and closed 20 in Q3 2020.
  • Nantahala Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.27B.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.